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Abstract
Background: Some women with depressive disorders experience severe premenstrual symptoms. However, there
have been few studies in which premenstrual symptoms in women suffering from depressive disorders were
assessed. In this study, we aimed to investigate premenstrual symptoms in women with depressive disorders using
the premenstrual dysphoric disorder (PMDD) scale.
Methods: We administered questionnaires to 65 Japanese female outpatients who had been diagnosed with a
major depressive disorder or dysthymic disorder and to 303 healthy women as control subjects. The questionnaire
consisted of items on demographics and the PMDD scale, which was modified from the premenstrual symptoms
screening tool (PSST) developed by Steiner et al. (Arch Womens Ment Health 2003, 6:203-209).
Results: Twenty-eight women (43.1%) with depressive disorder fulfilled certain items of the PMDD scale. These
women are considered to have coexisting PMDD and a depressive disorder, or to have premenstrual exacerbation
(PME) of a depressive disorder. On the other hand, 18 women (5.9%) in the control group were diagnosed as
having PMDD. The depressive disorder group who fulfilled the PMDD criteria had more knowledge of the term
premenstrual syndrome (PMS) and took more actions to attenuate premenstrual symptoms than the control group
with PMDD.
Conclusions: Our findings demonstrated that the occurrence of severe premenstrual symptoms is much higher in
women with depressive disorders than in healthy subjects. This is partially due to this group containing women
with PME, but mainly due to it containing women with PMDD. The higher percentage of PMDD suggests similarity
between PMDD and other depressive disorders. Furthermore, educating healthy Japanese women and women
with depressive disorders about premenstrual symptoms and evidence-based treatment for them is necessary.
Introduction
Approximately 80% of all women of reproductive age
experience physical and/or psychological changes in the
late luteal phase; i.e., the premenstrual period [1]. Physi-
cal changes include breast swelling, fatigue, headache,
and weight gain. Psychological changes include depres-
sive mood, irritability, and tension. These changes remit
after the onset of menstruation and are commonly
called premenstrual syndrome (PMS). However, PMS
has a broad concept and varies in severity. In the Inter-
national Classification of Diseases (10
th revision; ICD-
10), PMS was listed as “premenstrual tension” under
“Diseases of the Genitourinary System” [2].
Although many women complain of mild symptoms,
approximately 5% of women suffer from severe symp-
toms that lead to a reduction in quality of life [1]. In the
field of psychiatry, the diagnostic and statistical manual
of mental disorders, 3
rd edition, revised (DSM-III-R)
proposed a new diagnosis “late luteal phase dysphoric
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[3]. LLPDD is a severe variant of PMS and a dysphoric
disorder that interferes with social and occupational
functioning during the premenstrual period. Physical
symptoms are not required for the diagnosis of LLPDD.
In the diagnostic and statistical manual of mental disor-
ders, 4
th edition (DSM-IV) [4], a new diagnosis, “pre-
menstrual dysphoric disorder (PMDD)” is listed as a
criterion for further study instead of LLPDD. The
PMDD diagnosis is also based on the assumption that
the condition with the premenstrual symptoms is mainly
psychiatric and should be separated from a condition
with merely somatic complaints. Physical complaints are
not mandatory symptoms to meet the criteria for
PMDD or LLPDD.
T h eo u t l i n eo ft h ec r i t e r i af o rP M D Di ss h o w ni n
Table 1. Section A shows a list of symptoms. At least
o n eo ft h es y m p t o m s ,1 ,2 ,3 ,o r4 ,i sr e q u i r e df o rt h e
diagnosis. Symptoms 1, 2, 3, and 4 are related to moods
in depression. Section B shows a list of symptoms asso-
ciated with disturbance in ordinary life and relationships
with others. In section C, it is stated that an exacerba-
tion of another psychiatric disorder should be ruled out.
In section D, it is suggested that the diagnosis should be
confirmed prospectively within at least 2 months. How-
ever, a provisional diagnosis that is not confirmed pro-
spectively is allowed.
Because PMDD is a proposed diagnosis in DSM-IV,
PMDD is diagnosed as a “depressive disorder not other-
wise specified”. This indicates that PMDD is equivalent
to other depressive disorders in some way. Many studies
have found a correlation between premenstrual symp-
toms and depression. For example, women with PMDD
or PMS have a greater history of depression [5,6]. Lane
and Francis [7] estimated the percentage of women with
a lifetime history of affective disorders who have pre-
menstrual changes at roughly 60%. Moreover, women
with premenstrual symptoms demonstrated a more
severe depression than the control group [8-10].
In most studies, premenstrual symptoms in healthy
subjects have been investigated. However, studies in
which premenstrual symptoms were assessed in women
suffering from depressive disorders are few [5,11,12].
One reason for this is the difficulty in defining pre-
menstrual symptoms. If a woman with a depressive dis-
order experiences premenstrual symptoms, these
symptoms may coexist with PMS or occur as pre-
menstrual exacerbation (PME) of the depressive disor-
der. It is somewhat difficult to differentiate them. In this
study, we examined the percentage of women with
depressive disorders who fulfilled PMDD criteria using a
self-rating questionnaire; these women may have
i n c l u d e dt h o s ew i t hP M E ,a sw e l la st h o s ew i t hP M D D .
We compared the characteristics of these women with
healthy subjects with PMDD.
Methods
Subjects
This study was conducted from June to December in
2008 at a mental care clinic in the Institute of Women’s
Mental Health, Tokyo Women’s Medical University.
The ethics committee of Tokyo Women’s Medical Uni-
versity approved the conduct of this study.
Sixty-five female outpatients who had been diagnosed
as having a major depressive disorder or dysthymic dis-
order on the basis of DSM-IVcriteria [4] and whose
ages ranged from 20 to 45 years old were recruited.
They gave their written informed consent and com-
pleted a questionnaire. Through schools and offices, the
questionnaire was also distributed to 435 students,
employed women, working mothers, and housewives as
a control group. Their ages ranged from 20 to 45 years.
Three hundred twenty two women responded. Nineteen
(5.9%)of those who reported they were suffering from
depressive disorders or had a history of a depressive dis-
order were excluded. The remaining subjects (303) were
analyzed.
Table 1 Outline of PMDD criteria in DSM-IV [4]
A. In the menstruation cycles during the past year, the following
symptoms were present during the week prior to menstruation,
began to remit within a few days after the onset of menstruation,
and disappeared in the week postmenstruation.
Five symptoms, including one of (1), (2), (3), or (4) are necessary for
diagnosis
1 Depressive mood/feelings of
hopelessness
2 Anxiety/tension
3 Tearful/feeling suddenly sad
4 Anger/irritability/increased interpersonal conflicts
5 Decreased interest in work, school, or hobbies
6 Difficulty in concentrating
7 Easily fatigued/lethargy
8 Overeating/specific food cravings
9 Hypersomnia/Insomnia
10 Feeling out of
control
11 Physical symptoms such as breast tenderness or weight
gain
B. The disturbance interferes with work, school, usual social activities,
or relationships with others.
C. The disturbance is not an exacerbation of another disorder; such as
another depressive disorder or panic disorder.
D. Criteria must be confirmed using a prospective daily rating scale
during at least two consecutive symptomatic cycles. (The diagnosis
may be made provisionally prior to this confirmation.)
Miyaoka et al. BioPsychoSocial Medicine 2011, 5:5
http://www.bpsmedicine.com/content/5/1/5
Page 2 of 8Procedure
The questionnaire consisted of items on demographics
and the PMDD scale.
1. Demographics
Demographic information such as marital status, chil-
dren, and smoking was obtained. We also asked infor-
mation about the respondents’ menstruation: regularity
of cycles, physical symptoms during menstruation,
knowledge of PMS, and taking actions to attenuate its
symptoms.
2. PMDD scale
We developed the PMDD scale [13] based on DSM-
IVcriteria [4], which was modified from the premenstr-
ual symptoms screening tool (PSST) developed by Stei-
ner et al. [14]. The scale was found to have high
reliability and validity [13]. Respondents were first asked
whether they had any symptoms listed in the question-
naire that begin to appear one or two weeks prior to the
start of menstruation and disappear 2 or 3 days after
menstruation in most menstrual cycles during the past
year.
There are two parts to the PMDD scale. In the first
part, symptoms that were quoted from section A of the
PMDD criteria in DSM-IV [4] were listed. There are 11
symptoms listed in DSM-IV (Table 1). We formulated
two questions to distinguish between hypersomnia and
insomnia in section A, criterion 9. Therefore, the
PMDD scale consisted of 12 symptoms in section A. If
one answers “yes” (mild to severe) for at least one symp-
tom, she needed to answer the section B criteria in
DSM-IV. It consisted of five correlations about men-
struation interfering with activities or relationships.
As a result of a factor analysis, we found that there
were three factors in the scale, namely, “fatigue and/or
physical symptoms”, “depressive moods”,a n d“dysfunc-
tional relationships and/or anger” [13].
We diagnosed a subject as having PMDD if she
answered “severe” for at least one of the following items
in section A: depressive mood, anxiety, tearfulness, and
anger; answered “moderate” or “severe” for at least four
items in section A; and also answered “severe” for at
least one of the items in section B regarding the inter-
ference with activities and relationships.
Statistical analysis
Statistical analysis was conducted using SPSS version
16.0. The Student t-test and c
2 test were used to com-
pare the variables between the depressive disorder and
control groups. Significance tests were two-tailed.
Results
We compared 65 patients who were diagnosed with
major depressive disorder or dysthymic disorder and
303 control women in the general population who were
not suffering from depressive disorder and did not have
a history of it. Their ages ranged from 20 to 45 years.
We compared the average total score of the PMDD
scale between younger subjects (≦29 years old) and
older subjects (≧30 years old) using the Student t-test.
In the depressive disorder group, there was no signifi-
cant difference between the younger sub group and the
older sub group (younger, 41.9, vs. older, 45.9; p > .05).
Similarly, in the control group, there was no significant
difference between the younger group and the older
group (younger, 31.6 vs. older, 29.5; p > .05).
Table 2 shows the characteristics of the two groups.
T h ea v e r a g ea g eo ft h ed e p r e s s i v ed i s o r d e rg r o u pw a s
significantly higher than that of the control group.
However, the average ages of the two groups were in
the early 30’s; 34.8 years and 31.9 years old. The two
groups did not significantly differ in employment sta-
tus, regularity of the menstrual cycle, and incidence of
abdominal pain and/or lumbago during menstruation.
Statistically significant differences were observed for
Table 2 Characteristics of patients with depressive
disorders and control subjects
Variable Depressive
disorder group
Control
group
P
Number 65 303
Average age (SD) 34.8 (7.5) 31.9 (7.9) 0.007
Employed
Yes 33 136 n.s.
No 32 166
Married
Yes 17 147 0.001
No 47 156
Have children
Yes 16 117 0.033
No 49 186
Smoke cigarettes
Yes 18 33 0.000
No 47 267
Regular menstrual cycle
Yes 55 251 n.s.
No 9 52
Abdominal pain/lumbago in
menstruation
Yes 59 263 n.s.
No 6 38
Know the term PMS
Yes 56 213 0.009
No 9 90
SD: standard deviation
n.s.: not significant
PMS: premenstrual syndrome
Student t-test was used for the average age.
c
2 test was used for other variables.
Miyaoka et al. BioPsychoSocial Medicine 2011, 5:5
http://www.bpsmedicine.com/content/5/1/5
Page 3 of 8marital status, parity, smoking, and knowledge of the
term PMS.
Table 3 shows the characteristics of the two groups of
women. The first group consisted of 28 women (43.1%)
with variables for depressive disorders fulfilling the cri-
teria of PMDD determined using the PMDD scale. The
second group consisted of 18 women (5.9%) in the con-
trol group with variables also fulfilling the criteria of
PMDD determined using the PMDD scale. The percen-
tage of satisfaction of the criteria of PMDD in the
depressive disorder group was significantly higher than
that in the control group. The two groups of women
who fulfilled the criteria did not significantly differ in
employment or marital status, parity, smoking, or inci-
dence of abdominal pain and/or lumbago during men-
struation. There were significant differences between the
groups in regard to the regularity of the menstrual
cycle, knowledge of the term PMS, and taking actions to
attenuate premenstrual symptoms.
Table 4 shows the PMDD scale scores of the women
who fulfilled the PMDD criteria in the depressive disor-
der and control groups. The total PMDD score of the
women who fulfilled the PMDD criteria in the depres-
sive disorder group was higher than that of those in the
control group. There are three subscales. The depression
mood score of those who fulfilled the PMDD criteria in
the depressive disorder group was significantly higher
than that in the control group. There were no signifi-
cant differences in the scores for the items on fatigue/
physical symptoms and the dysfunctional relationship/
anger.
Table 5 shows the item scores for the women who ful-
filled the PMDD criteria in the depressive disorder and
control groups. The scores for depressive mood, anxiety,
tearfulness, decreased interests, and interference with
housework were significantly higher in the depressive
disorder group. There were no significant differences in
the scores for other items between the two groups.
Discussion
The percentages of women with depressive disorders
who fulfilled PMDD criteria
Before focusing on the main issue of this section, we
would firstly like to review some studies of the preva-
lence of PMDD among healthy women. Endicott [15]
pointed out that only about 3% to 8% of women have
sufficiently severe symptoms to meet the DSM-IV cri-
teria for PMDD, whereas many women experience some
premenstrual symptoms. In studies using diagnostic
structured interviews administered in community sam-
ples, Wittchen et al. [16] observed that the prevalence
of PMDD was 5.8% and Potter et al. [17] identified
12.2% of women having PMS and 4.1% having severe
PMS, which may have severe premenstrual symptoms
similar to PMDD symptoms. There were more studies
using questionnaires for the assessment of PMDD. Wal-
lenstein et al. [18] administered a questionnaire to
women who were 18-45 years old and were not being
treated for depression-related disorders. They identified
6.0% of these women as being at risk of PMDD. Cohen
et al. [19] diagnosed 6.4% of older women (36-44 years
old) as having PMDD using self-rating daily records
across a menstrual cycle. Otsubo and Owashi [20]
reported that 4.2% of women were identified as having
PMDD using a questionnaire based on the criteria of
Table 3 Characteristics of women fulfilling PMDD criteria
in depressive disorder and control groups
Variable Fulfillment of PMDD
criteria in depressive
disorder group
Fulfillment of
PMDD criteria in
control group
P
Fulfillment of
PMDD criteria
28 (43.1%) 18 (5.9%) 0.000
Average age
(SD)
34.9 (7.2) 30.7 (7.7) n.s.
Employed
Yes 14 7 n.s.
No 14 11
Married
Yes 7 7 n.s.
No 21 11
Have children
Yes 7 8 n.s.
No 21 10
Smoke cigarettes
Yes 9 1 n.s.
No 19 17
Regular
menstrual cycle
Yes 26 13 0.020
No 1 5
Abdominal pain/
lumbago in
menstruation
Yes 25 15 n.s.
No 3 3
Know the term
PMS
Yes 25 11 0.024
No 3 7
Taking action to
attenuate
symptoms
Yes 22 9 0.044
No 6 9
SD: standard deviation
n.s.: not significant
PMDD: premenstrual dysphoric disorder
PMS: premenstrual syndrome
Student t-test was used in the average age.
c
2 test was used for other variables.
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women appeared to have PMDD, as determined using a
questionnaire. Steiner et al. [14] determined the preva-
l e n c eo fP M D Dt ob e4 . 1 %u s i n gt h eP S S T .I nJ a p a n ,
Takeda et al. [22] developed a scale that was modified
from the PSST developed by Steiner et al. [14] and
observed a 1.2% prevalence of PMDD in Japan. It was
the lowest among those previously reported. The PMDD
s c a l et h a tw ed e v e l o p e dw a sa l s om o d i f i e df r o mt h e
PSST. In our previous study [13], the percentage of
Japanese women in a healthy group who fulfilled the
PMDD criteria was 5.9%. Our finding was similar to the
prevalence determined using the PSST developed by
Steiner et al. and those in many other studies.
Regarding the relationship between PMDD and
depression, we found that 43.1% of the women with
depressive disorders fulfilled the PMDD criteria deter-
mined using the PMDD scale. Many researchers have
Table 4 PMDD scale scores of women fulfilling PMDD criteria in depressive disorder and control groups
Fulfillment of PMDD criteria in depressive disorder
group
Fulfillment of PMDD criteria in control
group
P
mean SD mean SD
Score of subscales
Fatigue/physical symptoms 24.3 3.2 23.0 3.3 n.s.
Depression mood 13.4 2.9 9.4 3.5 0.000
Dysfunctional relationship/anger 17.4 3 16.2 2.3 n.s.
Total score 55.1 6.1 48.6 7.3 0.002
SD: standard deviation
n.s.: not significant
PMDD: premenstrual dysphoric disorder
Student t-test was used.
Table 5 Item scores of women fulfilling PMDD criteria in depressive disorder and control groups
Fulfillment of PMDD criteria in
depressive disorder group
Fulfillment of PMDD criteria in
control group
P
Number 28 18
Mean SD Mean SD
A Symptoms
1 Depressive mood/feelings of hopelessness 3.39 0.92 2.67 1.09 0.019
2 Anxiety/tension 3.39 0.79 2.56 1.15 0.011
3 Tearful/feeling suddenly sad 3.54 0.74 2.00 1.19 0.000
4 Anger/irritability/increased interpersonal conflicts 3.82 0.67 3.94 0.24 n.s.
5 Decreased interest in work, school, or hobbies 3.07 1.12 2.17 1.04 0.009
6 Difficulty in concentrating 3.25 1.01 3.33 0.59 n.s.
7 Easily fatigued/lethargy 3.75 0.65 3.72 0.58 n.s.
8 Overeating/specific food cravings 3.32 1.16 2.83 1.25 n.s.
9 Hypersomnia 3.32 1.02 3.44 0.98 n.s.
10 Insomnia 1.50 1.11 1.33 0.59 n.s.
11 Feeling out of control 3.75 0.70 3.33 1.03 n.s.
12 Physical symptoms† 3.93 0.26 3.78 0.55 n.s.
B Interfere with activities or relationships
1 Interfere with efficiency at work or school 3.18 1.25 3.00 1.14 n.s.
2 Interfere with housework 3.57 0.84 2.89 1.13 0.023
3 Interfere with relationships with coworkers 2.36 1.50 1.78 1.17 n.s.
4 Interfere with relationships with family 3.32 1.09 3.39 0.78 n.s.
5 Interfere with relationships with friends and acquaintances 2.61 1.07 2.39 1.20 n.s.
SD: standard deviation
n.s.: not significant
PMDD: premenstrual dysphoric disorder
†Symptoms such as breast tenderness or swelling, abdominal pain, headaches, joint or muscle pain, sensation of bloating, weight gain, or constipation.
Student t-test was used.
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other depressive disorders in women with PMDD or
PMS [5,6,11,12]. Soares et al. [6] found that the preva-
lence of PMDD was 6.3% and that over one half of the
women (55.6%) had a history of a depressive disorder.
Ito and Matsubara [12] observed that 31% of women
with depressive disorders were identified as having
PMDD using a questionnaire. Halbreich and Endicott
[5] evaluated current mental diagnoses using the
Research Diagnostic Criteria (RDC) and premenstrual
dysphoric changes using the Premenstrual Assessment
Form (PAF) in 170 women. Eighty-four percent of
women who met the criteria of major depressive disor-
der also had depressive mood changes during their pre-
menstrual period, whereas only 9% of women who were
not mentally ill experienced these mood changes. In our
current and previous reports [13], 43.1% of the women
with depressive disorders fulfilled PMDD criteria,
whereas 5.9% of the women without depressive disor-
ders did. Their findings support ours.
The diagnosis of PMDD is categorized as “depressive
disorder not otherwise specified”. This categorization
indicates that PMDD is closely related to depression in
symptomatology and characteristics. It suggests that pre-
menstrual changes, which include mild symptoms, are
also associated with mood changes. The issue of
whether women with PMS exhibit a greater severity of
depression throughout an entire menstrual cycle than
those without PMS is controversial [7]. In a report of
Morse et al. [8], women with PMS scored a significantly
greater severity of depression determined using the Beck
depression inventory (BDI) than control subjects who
did not complain of any premenstrual symptom in the
premenstrual phase. However, there was no difference
between the groups in the severity of depression in the
follicular phase. On the other hand some studies showed
that women experiencing premenstrual changes demon-
strate a greater severity of depression in not only the
premenstrual phase but also in the remaining phases of
the menstrual cycle [23,24].
Possibility of premenstrual symptoms being PMDD or
PME (premenstrual exacerbation)
The questionnaire cannot rule out the possibility of an
exacerbation of symptoms of depressive disorders.
Therefore, when a woman with a depressive disorder
fulfills the PMDD criteria determined using the ques-
tionnaire, her premenstrual symptoms cannot be clearly
defined as being coexistent with PMDD or PME. Pre-
vious studies indicated a high prevalence of PME in
women with a depressive disorder that ranged from 25%
to 80%. Kornstein et al. [25] showed that 64% of women
with a major depressive disorder reported premenstrual
worsening. Hsiao et al. [11] used structured interviews
and reported that the frequency of PMS was 80% in
patients with depressive disorders. This 80% included
cases of premenstrual exacerbation. The frequency of
premenstrual exacerbation was also high (52%). Depres-
sive patients who fulfill the PMDD criteria may include
those whose symptoms are merely an exacerbation of
symptoms of depressive disorders when a self-rating
s c a l ei su s e d .T h i sm a yb eo n eo ft h er e a s o n sw h yt h e
occurrence of premenstrual symptoms in the depressive
disorder group was higher than that in the control
group. In the criteria of PMDD in DSM-IV, an exacer-
bation of symptoms of other psychiatric disorders
should be ruled out. However, it is difficult to distin-
guish PMDD from an exacerbation of symptoms of
other psychiatric disorders because the PMDD scale is
self-rating. Although patients with premenstrual worsen-
ing of depressive disorders could not be ruled out using
the scale in the present study, the results showed that
the percentage of the women with depressive disorders
who experienced severe premenstrual symptoms was
higher than that of healthy subjects. It suggests similar-
ity between PMDD and other depressive disorders.
Characteristics of women with depressive disorders who
fulfilled PMDD criteria
We compared the PMDD symptoms listed in the ques-
tionnaire between the patients with depressive disorder
and the control group in terms of the total score and
depression mood subscale score (Table 4). The total
score and depression subscal es c o r ew e r eh i g h e ri nt h e
depressive disorder group. The depression mood sub-
scale consists of five items; ‘depressive mood/feeling of
hopelessness’, ‘anxiety/tension’, ‘tearful/feeling suddenly
sad’,a n d‘decreased interest in work, school or hobbies’.
The mean scores of all items of the depression mood
subscale among the depressive patients who fulfilled the
PMDD criteria were significantly higher than those of
the control subjects who were diagnosed as having
PMDD using the PMDD scale. In most other items, the
mean score was not significantly different between the
group with depressive disorders and the control group.
However, the group with depressive disorders scored
significantly higher in the item for interference with
housework, which was included in the dysfunctional
relationship/anger subscale (Table 5). The percentage of
married women who met the PMDD criteria was not
significantly different between the two groups (Table 3).
Therefore, the result was not due to marital status. It is
suggested that depressive women who fulfilled the
PMDD criteria feel the burden of housework in the pre-
menstrual period. We should pay attention to interfer-
ence with housework as well as deterioration of
depressive moods in the premenstrual period in depres-
sive patients.
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between the patients with depressive disorders who ful-
filled the PMDD criteria and control subjects who also
fulfilled them. Soares et al. [6] observed that women
with PMDD who also had a history of a depressive dis-
order were more likely to smoke, were less educated,
and more commonly married than the women with
PMDD without a history of it. However, we found no
significant difference in smoking or marital status
between the depressive disorder group who fulfilled the
PMDD criteria and the control group who fulfilled them
(Table 3). The present study revealed that the patients
in the depressive disorder group who fulfilled the
PMDD criteria were more knowledgeable about the
term “PMS” than the control subjects who were diag-
nosed as having PMDD. Some patients might have
known about PMS from being asked by their doctors.
T h ed e p r e s s i v ep a t i e n t sw i t hP M D Do rP M Ea l s ot o o k
more actions to attenuate premenstrual symptoms than
the control subjects with PMDD. The actions taken
include taking medicine prescribed by doctors. Further
education on premenstrual symptoms seems to be
required for healthy women because of their poor
knowledge of PMS and women with depressive disorder
because of the high percentage of such women with
severe premenstrual symptoms.
Limitations
There were several methodological limitations of this
study. Firstly, the sample size of patients was small and
they are only outpatients who had attended only one
clinic. Therefore, they could not represent all female
patients with depressive disorders. Secondly, as we men-
tioned earlier, the questionnaire cannot rule out the
possibility of exacerbation of symptoms of depressive
disorders. There is no certainty as to whether the
patients who fulfilled PMDD criteria had PMDD or
PME. Thirdly, the subjects were identified using a self-
rating questionnaire and diagnostic interviews were not
conducted. As a result, the determinations of PMDD
and PME were not conducted precisely. Lastly, it is
recommended that a diagnosis of PMDD should be con-
firmed after an observation lasting at least 2 months.
However, the questionnaire was administered only once,
not prospectively. Further study to investigate PMDD or
PME among women with depressive disorders is needed
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